SOURCE: ISTA Pharmaceuticals

ISTA Pharmaceuticals

February 09, 2012 07:30 ET

ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2011 Financial Results

IRVINE, CA--(Marketwire - Feb 9, 2012) - ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced it will release fourth quarter and full-year 2011 financial results after market on February 23, 2012. In conjunction, the Company will host a conference call at 4:30 p.m. Eastern Time focusing on its corporate and commercial activities and pipeline progress.

Date: Thursday, February 23, 2012
Time: 4:30 p.m. Eastern Time

Conference call access:
Domestic dial-in: 866-783-2138
International dial-in: 857-350-1597
Passcode: 14161724

To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 52781126. This conference call also will be webcast live and archived on ISTA's website until March 23, 2012.

ISTA Pharmaceuticals, Inc. is a fast growing and the third largest branded prescription eye care business in the United States with an expanding focus on allergy therapeutics. ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain, and nasal allergies. Headquartered in Irvine, California, ISTA generated revenues of $156.5 million in 2010. For additional information about ISTA, please visit the corporate website at

Contact Information